Find companies with promising cash flow potential yet trading below their fair value.
To own Amdocs, you need to believe large telecoms will keep investing in complex cloud, automation, and AI upgrades that require long-term partners. The latest quarter reinforces this demand with new multi-region wins, but the EPS guidance miss and flat backlog trend keep the main near term catalyst (cloud and GenAI projects scaling into revenue) and the biggest risk (muted telco spending and delayed transformations) firmly in focus rather than materially changing them.
Among the new deals, Amdocs’ cloud migration and digital transformation agreement with tier 1 operators such as TELUS and British Telecom stands out, because it ties directly to the core modernization and GenAI catalyst investors are watching. These multi-year wins support the view that Amdocs can deepen its role in telecom IT stacks even as overall industry capex and backlog growth remain under pressure.
Yet while new AI and cloud wins are encouraging, investors also need to be aware that...
Read the full narrative on Amdocs (it's free!)
Amdocs’ narrative projects $5.0 billion revenue and $970.1 million earnings by 2028.
Uncover how Amdocs' forecasts yield a $104.00 fair value, a 28% upside to its current price.
Two fair value estimates from the Simply Wall St Community span roughly US$104 to US$131 per share, underscoring how differently individual investors view Amdocs’ potential. Set this against the risk that telecom clients keep tightening or deferring digital transformation budgets, which could limit how quickly those optimistic scenarios play out.
Explore 2 other fair value estimates on Amdocs - why the stock might be worth just $104.00!
Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.
Early movers are already taking notice. See the stocks they're targeting before they've flown the coop:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com